FDAnews
www.fdanews.com/articles/84861-sun-pharma-switching-strategy

SUN PHARMA: SWITCHING STRATEGY

February 27, 2006

About a year ago, when executives at the Mumbai-based Sun Pharmaceutical Industries started drawing up budgets for the medium term, they were struck by the growth in spend in one cost centre: R&D. From just Rs 20 crore in 2000, the spend on R&D had soared to Rs 140 crore last year, and was projected to grow over 12 per cent annually over the next few years.

TMCnet (http://www.tmcnet.com/usubmit/2006/02/27/1409725.htm)